(Q37596495)

English

Inhibitors of the PI3K/Akt/mTOR pathway: new hope for breast cancer patients

scientific article published on January 2010

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

21 August 2017

1 reference

Europe PubMed Central

title

Inhibitors of the PI3K/Akt/mTOR pathway: new hope for breast cancer patients (English)

1 reference

stated in

Europe PubMed Central

21 August 2017

0 references

1 reference

Sandra E Ghayad

1

1 reference

stated in

Europe PubMed Central

PubMed ID

19751211

retrieved

21 August 2017

Pascale A Cohen

series ordinal

2

1 reference

stated in

Europe PubMed Central

21 August 2017

1 January 2010

1 reference

stated in

Europe PubMed Central

21 August 2017

Recent Patents on Anti-Cancer Drug Discovery

1 reference

stated in

Europe PubMed Central

21 August 2017

5

1 reference

stated in

Europe PubMed Central

21 August 2017

29-57

1 reference

stated in

Europe PubMed Central

21 August 2017

1

1 reference

stated in

Europe PubMed Central

21 August 2017

Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.28.727

Identifiers

DOI

10.2174/157489210789702208

1 reference

stated in

Europe PubMed Central

21 August 2017

1 reference

Europe PubMed Central

PubMed ID

19751211

retrieved

21 August 2017

(Q37596495)

Inhibitors of the PI3K/Akt/mTOR pathway: new hope for breast cancer patients

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)